In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas

BackgroundEpstein–Barr virus (EBV) quantitation and current imaging modalities are used for diagnosis and disease monitoring in Extranodal NK/T cell lymphoma (ENKTL) but have limitations. Thus, we explored the utility of circulating tumor DNA (ctDNA) as a diagnostic biomarker.MethodsThrough in-depth...

Full description

Bibliographic Details
Main Authors:	Jin Ju Kim, Hyun-Young Kim, Zisun Choi, So yoon Hwang, Hansol Jeong, Jong Rak Choi, Sang Eun Yoon, Won Seog Kim, Sun-Hee Kim, Hee-Jin Kim, Sang-Yong Shin, Seung-Tae Lee, Seok Jin Kim
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Oncology
Subjects:	liquid biopsy Extranodal natural killer/T cell lymphoma biomarker CtDNA molecular biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1109715/full

Similar Items

Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer
by: Namsoo Kim, et al.
Published: (2022-08-01)

Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review
by: Seok Jin Kim, et al.
Published: (2018-12-01)

Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non‐small cell lung cancer
by: Myeong Geun Choi, et al.
Published: (2020-11-01)

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
by: Junhun Cho, et al.
Published: (2021-08-01)

A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma : a multicenter study
by: Tan, Khee Ming, et al.
Published: (2020)

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study
by: Clemente Humberto Zúñiga, et al.
Published: (2025-02-01)

Pancreas Involvement of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Presenting as Acute Pancreatitis: A Case Report
by: Dong Wook Lee, et al.
Published: (2022-07-01)

Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma
by: Joo Young Ha, et al.
Published: (2020-11-01)

Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous system
by: Sang Eun Yoon, et al.
Published: (2020-07-01)

Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia
by: Sang Eun Yoon, et al.
Published: (2021-05-01)

MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma
by: Kyung Ju Ryu, et al.
Published: (2025-02-01)

Extranodal Natural Killer/T-Cell Lymphoma: A Rare Nasal-Type Case
by: Esra Sarıbacak Can, et al.
Published: (2016-02-01)

Prognostic value of single‐nucleotide polymorphisms for extranodal natural killer/T‐cell lymphoma: the identification of risk factors in the molecular era
by: Sang Eun Yoon, et al.
Published: (2021-11-01)

Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma
by: Lin-Shu Zeng, et al.
Published: (2017-12-01)

Validation of presepsin measurement for mortality prediction of sepsis: a preliminary study
by: Seung Min Baik, et al.
Published: (2022-11-01)

Prognostic evaluation of extranodal natural killer/T-cell lymphoma, nasal type(ENKTL) with 18F-FDG PET/CT
by: WANG Jin, GUO Rui, LI Biao, ZHANG Xiaozhe
Published: (2022-12-01)

Decreased natural killer cell activity as a potential predictor of hypertensive incidence
by: Yun-Kyong Lee, et al.
Published: (2024-04-01)

Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation
by: Edmond M. Kwan, et al.
Published: (2022-11-01)

Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy.
by: Borahm Kim, et al.
Published: (2019-01-01)

Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
by: Jang Ho Cho, et al.
Published: (2021-05-01)

Extranodal natural killer/T-cell lymphoma with paraneoplastic eosinophilic myositis
by: Jayati Mallick, et al.
Published: (2020-09-01)

Natural Killer-cell Enteropathy of the Stomach in an Elderly Woman: A Case Report
by: Ye young Koo, et al.
Published: (2021-12-01)

Extranodal Natural Killer/T-Cell Lymphoma of the Nasal Type with Skin Metastases
by: Fadi Al Akhrass, et al.
Published: (2016-01-01)

Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ
by: Hyun‐Hee Koh, et al.
Published: (2023-10-01)

Tailoring tumor-recognizable hyaluronic acid–lipid conjugates to enhance anticancer efficacies of surface-engineered natural killer cells
by: Chae Eun Lee, et al.
Published: (2023-12-01)

Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
by: Devraj Kandel, MD, et al.
Published: (2023-11-01)

Evaluation of cardiopulmonary and inflammatory markers in dogs with heartworm infection during treatment with the 2014 American Heartworm Society recommended treatment protocol
by: Won-Kyoung Yoon, et al.
Published: (2017-11-01)

Natural Killer Cell Activity and Interleukin-12 in Metabolically Healthy versus Metabolically Unhealthy Overweight Individuals
by: Minjoo Kim, et al.
Published: (2017-11-01)

Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy
by: Eun-Jeong Won, et al.
Published: (2024-08-01)

The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma
by: Sang Eun Yoon, et al.
Published: (2023-11-01)

Corrigendum: Natural Killer Cell Activity and Interleukin-12 in Metabolically Healthy versus Metabolically Unhealthy Overweight Individuals
by: Minjoo Kim, et al.
Published: (2018-09-01)

A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B‐cell lymphoma
by: Hyunjee Lee, et al.
Published: (2023-08-01)

Unified framework for brain connectivity-based biomarkers in neurodegenerative disorders
by: Sung-Woo Kim, et al.
Published: (2022-09-01)

Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy
by: Jae Sik Kim, et al.
Published: (2023-01-01)

Reanalysis of Genomic Sequencing Results in a Clinical Laboratory: Advantages and Limitations
by: Dongju Won, et al.
Published: (2020-06-01)

Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate
by: Yoon Seok Suh, et al.
Published: (2017-09-01)

Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models
by: Ho Yong Kim, et al.
Published: (2022-12-01)

Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages
by: Brittany A. McKelvey, et al.
Published: (2024-04-01)

Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
by: Arum Park, et al.
Published: (2018-08-01)

IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
by: Yeon Ho Choi, et al.
Published: (2019-07-01)